JOURNAL ARTICLE
RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

Isometric parameters in the monitoring of maximal strength, power, and hypertrophic resistance-training.

This study monitored strength-training adaptations via isometric parameters throughout 2 × 10 weeks of hypertrophic (HYP I-II) or 10 weeks maximum strength (MS) followed by 10 weeks power (P) training with untrained controls. Trainees performed bilateral isometric leg press tests analyzed for peak force (maximal voluntary contraction (MVC)) and rate of force development (RFD) every 3.5 weeks. These parameters were compared with dynamic performance, voluntary and electrically induced isometric contractions, muscle activity, and cross-sectional area (CSA) in the laboratory before and after 10 and 20 weeks. RFD increased similarly during the first 7 weeks (HYP I, 44% ± 53%; MS, 48% ± 55%, P < 0.05), but RFD continued to increase up to 65% ± 61% from baseline (P < 0.01) only during P. These increases were concomitant with enhanced dynamic performances of 1-repetition maximum (1RM) (HYP I, 8% ± 6%; MS, 11% ± 6%, P < 0.001), and explosive repetitions during P (11% ± 15%, P < 0.05). Time to reach peak RFD differed (P < 0.001) between HYP (mean 42 ± 20 ms) and MS-P (mean 31 ± 12 ms) groups because of training. The changes in MVC correlated with the changes in CSA during weeks 1-20 (HYP I-II, r = 0.664; MS-P, r = 0.595, P ≤ 0.05), as well as changes in 1RM (r = 0.724, P < 0.05) during weeks 11-20 (HYP II). Muscle activity increased during MS and P only. Both MVC and RFD improvements reflected combinations of central and peripheral adaptations. RFD parameters may be effective tools to evaluate adaptations, particularly during maximal strength/power training, while MVC cannot distinguish between strength or muscle mass changes. Monitoring RFD provided important information regarding plateaus in RFD improvement, which were observed in dynamic explosive performances after HYP II compared with P.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app